Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
FUT6 (human)

Overview
FUT6 Enzyme involved in the biosynthesis of the E-Selectin ligand, sialyl-Lewis X. Catalyzes the transfer of fucose from GDP- beta-fucose to alpha-2,3 sialylated substrates. Belongs to the glycosyltransferase 10 family. 2 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Transferase; EC 2.4.1.65; Membrane protein, integral; Glycan Metabolism - glycosphingolipid biosynthesis - lacto and neolacto series
Cellular Component: Golgi apparatus; integral to membrane
Molecular Function: 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity; alpha(1,3)-fucosyltransferase activity; fucosyltransferase activity
Biological Process: protein amino acid glycosylation; L-fucose catabolic process
Reference #:  P51993 (UniProtKB)
Alt. Names/Synonyms: Alpha-(1,3)-fucosyltransferase; FCT3A; FLJ40754; FT1A; Fuc-TVI; Fucosyltransferase 6; fucosyltransferase 6 (alpha (1,3) fucosyltransferase); Fucosyltransferase VI; FucT-VI; FUT6
Gene Symbols: FUT6
Molecular weight: 41,860 Da
Basal Isoelectric point: 8.92  Predict pI for various phosphorylation states
Select Structure to View Below

FUT6

Protein Structure Not Found.


STRING  |  neXtProt  |  Protein Atlas  |  BioGPS  |  DISEASE  |  Scansite  |  Pfam  |  ENZYME  |  Phospho.ELM  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene  |  InnateDB


Modification Sites and Domains  

Modification Sites in Parent Protein, Orthologs, and Isoforms  
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 S123-p PSAQLPRsPRRQGQR
0 1 Y208-p PNSARVRyyQSLQAH
0 1 Y209-p NSARVRyyQSLQAHL
0 1 Y221-p AHLKVDVyGRSHKPL
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.